(92) conducted a 16-week randomized, double-blind, controlled trial with 196 patients, finding that omega-3 PUFAs significantly reduced the total number of migraine attacks compared to placebo, though a strong placebo effect was observed, and the study did not confirm earlier findings from smaller studies
After two years of trials, involving more than 400 adults with OPS, researchers have published the abstract of their findings in the New England Journal of Medicine
Switching medications and timing If you are transitioning from semaglutide to tirzepatide (or vice versa), timing becomes especially important
The recommended dose for GBB is currently 25mg-50mg once per day, although you may also take 25mg twice a day
FDA press announcement (2025) 11
Because of Novo Nordisks patents, generic semaglutide products will not be able to enter the U.S